| Parameter | Adolescents during Growth Hormone Therapy n = 14 | Same Adolescents after Cessation n = 14 | |
| Age [years] | 17.2 ± 2.1 |
|
|
| female/male | 9/5 |
|
|
| GHD/SGA | 11/3 |
|
|
| ADHD | 4 |
|
|
| Birth weight [g] | 2779 ± 972 |
|
|
| Height [cm] | 161.3 ± 8.6 |
|
|
| Height SDS | −1.44 ± 0.59 |
|
|
| BMI [kg/m2] | 21.3 ± 2.8 |
|
|
| BMI Percentile [%] | 53 ± 28 |
|
|
|
| Mean ± SD | Mean ± SD | P-value |
| Heart Rate [bpm] | 84.9 ± 6.2 | 79.4 ± 8.5* | 0.048 |
| HR day [bpm] | 93.6 ± 6.6 | 88.8 ± 10.2 |
|
| HR night [bpm] | 71.8 ± 6.8 | 64.3 ± 7.0** | 0.0013 |
| RMSSD [ms] | 39.6 ± 9.9 | 42.4 ± 11.5 |
|
| pNN50 [%] | 20.6 ± 9.3 | 22.3 ± 10.3 |
|
| SDNN [ms] | 150.6 ± 27.2 | 180.6 ± 33.8** | 0.0018 |
| Total Power [ms2] | 5019 ± 1845 | 5757 ± 2582 |
|
| Very Low Frequency [ms2] | 2865 ± 1144 | 3388 ± 1717 |
|
| Low Frequency [ms2] | 1377 ± 655 | 1596 ± 774 |
|
| High Frequency [ms2] | 698 ± 213 | 707 ± 267 |
|
| HF/LF Ratio | 0.558 ± 0.204 | 0.488 ± 0.211 |
|